RESUMEN
PURPOSE: Glioblastoma multiforme (GBM) is the most lethal form of brain cancer with a median survival of only 12 to 15 months. Current standard treatment consists of surgery followed by chemoradiation. The poor survival of patients with GBM is due to aggressive tumor invasiveness, an inability to remove all tumor tissue, and an innate tumor chemo- and radioresistance. Ataxia-telangiectasia mutated (ATM) is an excellent target for radiosensitizing GBM because of its critical role in regulating the DNA damage response and p53, among other cellular processes. As a first step toward this goal, we recently showed that the novel ATM kinase inhibitor KU-60019 reduced migration, invasion, and growth, and potently radiosensitized human glioma cells in vitro. EXPERIMENTAL DESIGN: Using orthotopic xenograft models of GBM, we now show that KU-60019 is also an effective radiosensitizer in vivo. Human glioma cells expressing reporter genes for monitoring tumor growth and dispersal were grown intracranially, and KU-60019 was administered intratumorally by convection-enhanced delivery or osmotic pump. RESULTS: Our results show that the combined effect of KU-60019 and radiation significantly increased survival of mice 2- to 3-fold over controls. Importantly, we show that glioma with mutant p53 is much more sensitive to KU-60019 radiosensitization than genetically matched wild-type glioma. CONCLUSIONS: Taken together, our results suggest that an ATM kinase inhibitor may be an effective radiosensitizer and adjuvant therapy for patients with mutant p53 brain cancers.
Asunto(s)
Proteínas de la Ataxia Telangiectasia Mutada/genética , Neoplasias Encefálicas/terapia , Glioma/terapia , Morfolinas/administración & dosificación , Tioxantenos/administración & dosificación , Animales , Proteínas de la Ataxia Telangiectasia Mutada/antagonistas & inhibidores , Neoplasias Encefálicas/patología , Línea Celular Tumoral , Citometría de Flujo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Glioma/patología , Humanos , Ratones , Mutación , Tolerancia a Radiación/efectos de los fármacos , Radiación Ionizante , Proteína p53 Supresora de Tumor/genéticaRESUMEN
Water-soluble camptothecin (CPT)-polyoxetane conjugates were synthesized using a clickable polymeric platform P(EAMO) that was made by polymerization of acetylene-functionalized 3-ethyl-3-(hydroxymethyl)oxetane (i.e., EAMO). CPT was first modified with a linker 6-azidohexanoic acid via an ester linkage to yield CPT-azide. CPT-azide was then click coupled to P(EAMO) in dichloromethane using bromotris(triphenylphosphine)copper(I)/N,N-diisopropylethylamine. For water solubility and cytocompatibility improvement, methoxypolyethylene glycol azide (mPEG-azide) was synthesized from mPEG 750 g mol(-1) and click grafted using copper(II) sulfate and sodium ascorbate to P(EAMO)-g-CPT. (1)H NMR spectroscopy confirmed synthesis of all intermediates and the final product P(EAMO)-g-CPT/PEG. CPT was found to retain its therapeutically active lactone form. The resulting P(EAMO)-g-CPT/PEG conjugates were water-soluble and produced dose-dependent cytotoxicity to human glioma cells and increased γ-H2AX foci formation, indicating extensive cell cycle-dependent DNA damage. Altogether, we have synthesized CPT-polymer conjugates able to induce controlled toxicity to human cancer cells.
Asunto(s)
Antineoplásicos Fitogénicos/química , Neoplasias Encefálicas/patología , Camptotecina/química , Química Clic , Glioma/patología , Polímeros/síntesis química , Glicoles de Propileno/química , Antineoplásicos Fitogénicos/metabolismo , Neoplasias Encefálicas/tratamiento farmacológico , Camptotecina/metabolismo , Supervivencia Celular/efectos de los fármacos , Glioma/tratamiento farmacológico , Humanos , Luciferasas/metabolismo , Estructura Molecular , Polietilenglicoles/química , Polietilenglicoles/metabolismo , Polímeros/química , Polímeros/metabolismo , Glicoles de Propileno/metabolismo , Solubilidad , Células Tumorales Cultivadas , Agua/químicaRESUMEN
Contact hypersensitivity (CHS) is a type of cutaneous inflammation that is exacerbated by neurogenic factors. Both mu- and kappa-opioids enhance CHS to a greater extent in females than males. It was hypothesized that potentiated neurokinin 1 (NK1) receptor signaling following opioid treatment accounts for sex differences in the magnitude of CHS. Following morphine or spiradoline treatment the NK1 receptor antagonist SR140,333 significantly attenuated the magnitude of CHS in females but not males. By contrast, the NK2 antagonist SR48968 had no effect on morphine modulation of CHS. Taken together, these data indicate that NK1 receptor signaling is a key mediator of sex differences in opioid-induced enhancement of CHS.
Asunto(s)
Dermatitis por Contacto/metabolismo , Receptores de Neuroquinina-1/metabolismo , Receptores Opioides kappa/agonistas , Receptores Opioides mu/agonistas , Caracteres Sexuales , Analgésicos Opioides/farmacología , Animales , Benzamidas/farmacología , Interacciones Farmacológicas , Femenino , Masculino , Morfina/farmacología , Antagonistas del Receptor de Neuroquinina-1 , Piperidinas/farmacología , Pirrolidinas/farmacología , Quinuclidinas/farmacología , Ratas , Ratas Endogámicas F344 , Receptores de Neuroquinina-2/antagonistas & inhibidores , Receptores Opioides kappa/metabolismo , Receptores Opioides mu/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Organismos Libres de Patógenos Específicos , Sustancia P/metabolismoRESUMEN
Neonatal ethanol exposure in animals results in performance deficits on tests of hippocampus-dependent spatial memory, and recent studies have shown that extra dietary choline can ameliorate some of these impairments. In this experiment, rats were administered 5.25 g/kg ig ethanol per day or sham intubations on Postnatal Days (PD) 4-9 and choline (0.1 ml of an 18.8 mg/ml solution) or saline subcutaneously on PD 4-20. On PD 30, rats were given delay or trace fear conditioning trials and were tested for conditioned stimulus-elicited freezing 24 hr later. Neonatal ethanol produced a profound impairment in trace conditioning that was reversed by choline. Groups did not differ in delay conditioned responding, indicating that neonatal ethanol produces a relatively selective cognitive deficit that can be alleviated with supplemental choline.